LB Pharmaceuticals Inc filed an 8-K on March 10, 2026, disclosing matters under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements, along with Item 7.01 referencing a press release in Exhibit 99.1 dated March 9, 2026.
Key takeaways
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure with Exhibit 99.1 Press Release dated March 9, 2026
Item 9.01: Financial Statements and Exhibits including Exhibit 99.1 and Exhibit 104 Cover Page Interactive Data File
Filing Date: 2026-03-10
Company: LB Pharmaceuticals Inc Common Stock (LBRX)